Cargando…

KDM3A is not associated with metastasis and prognosis of breast cancer

Lysine demethylase 3A (KDM3A), also known as JMJD1A, has been associated with metastasis and poor prognosis in several cancer types, including renal cell carcinoma, prostate cancer and Ewing sarcoma. However, little is known regarding the clinicopathological significance of KDM3A expression in breas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, Juan, Zheng, Shutao, Li, Baiyan, Li, Xinxin, Liu, Wenya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6004682/ https://www.ncbi.nlm.nih.gov/pubmed/29928349 http://dx.doi.org/10.3892/ol.2018.8578

Ejemplares similares

Histone demethylase KDM6B inhibits breast cancer metastasis by regulating Wnt/β‐catenin signaling
por: Xun, Jing, et al.
Publicado: (2021)

Regulation of KDM5C stability and enhancer reprogramming in breast cancer
por: Xiao, Qiong, et al.
Publicado: (2022)

JAG1 is associated with the prognosis and metastasis in breast cancer
por: Qiao, Xiaojuan, et al.
Publicado: (2022)

The Histone Demethylase Enzymes KDM3A and KDM4B Co-Operatively Regulate Chromatin Transactions of the Estrogen Receptor in Breast Cancer
por: Jones, Dominic, et al.
Publicado: (2019)

Epigenetic regulator KDM4A activates Notch1-NICD-dependent signaling to drive tumorigenesis and metastasis in breast cancer
por: Pei, Jing, et al.
Publicado: (2022)

KDM6A-ARHGDIB axis blocks metastasis of bladder cancer by inhibiting Rac1
por: Liu, Lei, et al.
Publicado: (2021)

KDM4 Involvement in Breast Cancer and Possible Therapeutic Approaches
por: Varghese, Benluvankar, et al.
Publicado: (2021)

Fbxo22 inhibits metastasis in triple-negative breast cancer through ubiquitin modification of KDM5A and regulation of H3K4me3 demethylation
por: Li, Siqiaozhi, et al.
Publicado: (2022)

KDM3A and KDM3B Maintain Naïve Pluripotency Through the Regulation of Alternative Splicing
por: Dillingham, Caleb, et al.
Publicado: (2023)

KDM6B-mediated histone demethylation of LDHA promotes lung metastasis of osteosarcoma
por: Jiang, Yuhang, et al.
Publicado: (2021)

Survival analysis and prognosis of patients with breast cancer with pleural metastasis
por: Li, Sumei, et al.
Publicado: (2023)

Investigation of the Mechanism of hsa_circ_000 1429 Adsorbed miR-205 to Regulate KDM4A and Promote Breast Cancer Metastasis
por: Xu, Yuting, et al.
Publicado: (2022)

SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockade
por: Romero, Octavio A., et al.
Publicado: (2021)

The Dual Function of KDM5C in Both Gene Transcriptional Activation and Repression Promotes Breast Cancer Cell Growth and Tumorigenesis
por: Shen, Hai‐feng, et al.
Publicado: (2021)

circKDM4C enhances bladder cancer invasion and metastasis through miR-200bc-3p/ZEB1 axis
por: Ma, Xueyou, et al.
Publicado: (2021)

KDM6B promotes gastric carcinogenesis and metastasis via upregulation of CXCR4 expression
por: Liu, Fen, et al.
Publicado: (2022)

RUFY3 Predicts Poor Prognosis and Promotes Metastasis through Epithelial-mesenchymal Transition in Lung Adenocarcinoma
por: Men, Wanfu, et al.
Publicado: (2019)

Small molecule KDM4s inhibitors as anti-cancer agents
por: Lin, Hongzhi, et al.
Publicado: (2018)

Overexpression of KDM5B/JARID1B is associated with poor prognosis in hepatocellular carcinoma
por: Shigekawa, Yoshinobu, et al.
Publicado: (2018)

KDM2A and KDM3B as Potential Targets for the Rescue of F508del-CFTR
por: D’Amore, Claudio, et al.
Publicado: (2022)

KDM6 Demethylases and Their Roles in Human Cancers
por: Hua, Chunyan, et al.
Publicado: (2021)

The histone demethylase enzyme KDM3A is a key estrogen receptor regulator in breast cancer
por: Wade, Mark A., et al.
Publicado: (2015)

Metastasis-associated protein 3 in colorectal cancer determines tumor recurrence and prognosis
por: Huang, Yi, et al.
Publicado: (2017)

KDM5C Expedites Lung Cancer Growth and Metastasis Through Epigenetic Regulation of MicroRNA-133a
por: Zhang, Quan, et al.
Publicado: (2021)

KDM3A and KDM4C Regulate Mesenchymal Stromal Cell Senescence and Bone Aging via Condensin-mediated Heterochromatin Reorganization
por: Huang, Biao, et al.
Publicado: (2019)

KDM5B overexpression predicts a poor prognosis in patients with squamous cell carcinoma of the head and neck
por: Huang, Donghai, et al.
Publicado: (2018)

KDM5 lysine demethylases are involved in maintenance of 3′UTR length
por: Blair, Lauren P., et al.
Publicado: (2016)

KDM3A regulates Slug expression to promote the invasion of MCF7 breast cancer cells in hypoxia
por: Ahn, Hyun-Jung, et al.
Publicado: (2020)

Predictive Models for Colon Adenocarcinoma Diagnosis, Prognosis, and Immune Microenvironment Based on 2 Hypoxia-Related Genes: KDM3A and ENO3
por: Kong, Chunli, et al.
Publicado: (2023)

Upregulated osterix promotes invasion and bone metastasis and predicts for a poor prognosis in breast cancer
por: Yao, Bing, et al.
Publicado: (2019)

Prognosis and Genomic Landscape of Liver Metastasis in Patients With Breast Cancer
por: Tian, Chonglin, et al.
Publicado: (2021)

KDM6A and KDM6B play contrasting roles in nuclear transfer embryos revealed by MERVL reporter system
por: Yang, Lei, et al.
Publicado: (2018)

Intravesical delivery of KDM6A-mRNA via mucoadhesive nanoparticles inhibits the metastasis of bladder cancer
por: Kong, Na, et al.
Publicado: (2022)

KDM2B overexpression correlates with poor prognosis and regulates glioma cell growth
por: Wang, Yiwei, et al.
Publicado: (2018)

The emerging role of KDM5A in human cancer
por: Yang, Guan-Jun, et al.
Publicado: (2021)

The histone demethylase KDM3A, and its downstream target MCAM, promote Ewing Sarcoma cell migration and metastasis
por: Sechler, Marybeth, et al.
Publicado: (2017)

KDM2B in papillomavirus-related cancer
por: Peta, Elektra, et al.
Publicado: (2018)

Role for the Histone Demethylase KDM4B in Rhabdomyosarcoma via CDK6 and CCNA2: Compensation by KDM4A and Apoptotic Response of Targeting Both KDM4B and KDM4A
por: Walters, Zoë S., et al.
Publicado: (2021)

Cystic brain metastasis is associated with poor prognosis in patients with advanced breast cancer
por: Sun, Bing, et al.
Publicado: (2016)

High KDM1A Expression Associated with Decreased CD8+T Cells Reduces the Breast Cancer Survival Rate in Patients with Breast Cancer
por: Kim, Hyung Suk, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s8eqsblsihomhiqjhn8q2c0kv2